The Chemical Discovery Behind the First Oral Contraceptive Pill
A 1952 patent for a synthetic hormone that became the active ingredient in the first effective oral contraceptive pill.
Patent Number
US 2744122
Status
Expired
Filing Date
November 12, 1952
Grant Date
May 1, 1956
Expiration
May 1, 1973
Claims
1
Assignee
Syntex SA
Inventors
Djerassi Carl, Miramontes Luis, Rosenkranz George
Citations
19 forward · 3 backward
What it covers
The patent describes the chemical synthesis of a specific steroid compound known as 19-nor-17alpha-ethinyltestosterone, later called norethindrone. By removing a carbon atom from the standard testosterone structure and adding an ethinyl group, the inventors created a molecule that remains stable and active when taken orally. This compound mimics the body's natural progesterone, effectively suppressing ovulation to prevent pregnancy.
What it doesn't cover
- —Does not cover the final pharmaceutical delivery mechanism or pill formulation.
- —Does not cover other synthetic progestins developed after this specific chemical structure.
- —Does not cover the medical method of using the compound for contraception.
The clever bit
The inventors realized that removing the C-19 methyl group from the testosterone molecule significantly increased its potency when ingested, overcoming the problem of the liver breaking down hormones before they could reach the bloodstream.
Why it matters
This discovery transformed reproductive health and social structures in the 20th century. It provided the chemical foundation for the birth control pill, which allowed women unprecedented control over their reproductive lives and fundamentally changed global labor markets and family planning.
Real-world examples
- 1.Norethindrone-based oral contraceptives
- 2.Hormone replacement therapy medications
Generated by PatentBrief · Not legal advice · patentbrief.org
US 2744122 · 2026